Radiolabelled mixed leukocytes and pure granulocytes with stabilized 99tcm-exametazime

Nuclear Medicine Communications

Volumn 19, Issue 10, 1998, Pages 981-988

  Hung, J C ^a   Chowdhury, S ^a   Mullan, B P ^a   Mahoney, D W ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; TRYPAN BLUE;

ARTICLE; CELL VIABILITY; GRANULOCYTE; HUMAN; HUMAN CELL; ISOTOPE LABELING; MIXED LEUKOCYTE CULTURE; SEDIMENTATION RATE;

CELL SURVIVAL; GRANULOCYTES; HUMANS; LEUKOCYTES; TECHNETIUM TC 99M EXAMETAZIME;

EID: 0031796238     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199810000-00008     Document Type: Article

References (14)

1. Ceretec® kit for the preparation of technetium Tc99m exametazime injection package insert. Arlington Heights, IL, USA: Medi-Physics, Inc., Amersham Healthcare, May 1995.
2. Hung JC, Chowdhury S, Mullan BP. Use of stabilized tech-netium-99m-exametazime for radiolabeling leukocytes. J Nucl Med 1998; 39: 912-917.
3. Thakur ML, Seifert CL, Madsen MT, McKenney SM, Desai AG, Park CH. Neutrophil labeling: Problems and pitfalls. Sem Nucl Med 1984; 14: 107-117.
4. Thorson LM, Turkalj A, Hung JC. In vitro evaluation of neutrophil viability after exposure to a hypotonic medium. Nucl Med Commun 1995; 16: 615-620.
5. Thorson LM, Turkalj A, Hung JC. Evaluation of a new single-gradient, Ficoll-Hypaque with hypotonic lysis method for leukocyte separation. J Nucl Med Technol 1995; 23: 282-288.
6. Jurisson S, Schlemper EO, Troutner DE, Canning LR, Nowotnik DP, Neirinckx RD. Synthesis, characterization, and x-ray structural determination of technetium(V)-oxo-tetradentate amine oxime complexes. Inorg Chem 1986; 25: 543-549.
7. Hung JC, Taggart TR, Wilson ME, Owens TP. Radiochemical purity testing for 99Tcm-exametazime: A comparison study for three-paper chromatography. Nucl Med Commun 1994; 15: 569-574.
8. Ceretec® technetium-99m exametazime agent package insert. Amersham, UK: Amersham International pic, June 1989.
9. Peters AM, Danpure HJ, Osman S et al. Clinical experience with 99Tcm-hexamethylpropyleneamine oxime for labeling leukocytes and imaging inflammation. Lancet 1986; 2: 946-949.
10. Costa DC, Lui D, Ell PJ. White cells radiolabeled with mIn and 99Tcm: A study of relative sensitivity and in vivo viability. Nucl Med Commun 1988; 9: 725-731.
11. Danpure HJ, Osman S, Carroll MJ. The development of a clinical protocol for the radiolabelling of mixed leucocytes with 99Tcm-hexamethylpropyleneamine oxime. Nucl Med Commun 1988; 9: 465-475.
12. Scholmerich J, Schmidt E, Shiimichen C, Billmann P, Schmidt H, Gerok W. Scintigraphic assessment of bowel involvement and disease activity in Crohn’s disease using technetium 99m-hexamethyl propylene amine oxime as a leucocyte label. Gastroenterology 1988; 95: 1287-1293.
13. Arndt J-W, vanderSluysVeer A, Blok D et al. Prospective comparative study of technetium-99m-WBCs and indium-111-granulocytes for the examination of patients with inflammatory bowel disease. J Nucl Med 1993; 34: 1052-1057.
14. Peters AM. The utility of [99mTc] HMPAO-leukocytes for imaging infection. Sem Nucl Med 1994; 24: 110-127.